Centrexion Therapeutics
-$0.10 (-4.95%) As of 5:20 PM UTC today
Why Robinhood?
You can watch CNTX and buy or sell other stocks, options, and ETFs commission-free!
About CNTX
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers.
CEO
Martin A. Lehr
Employees
7
Headquarters
Philadelphia, Pennsylvania
Founded
2015
CNTX Key Statistics
Market cap
30.65M
Price-Earnings ratio
—
Dividend yield
—
Average volume
260.21K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$10.87
52 Week low
$1.27